Contact details
Personal links
About
Overview
Dr Robert Noble uses mathematical and computational models to investigate the evolution and ecology of cancer, in collaboration with experimental biologists and clinicians.
Dr Noble obtained a DPhil in Zoology from the University of Oxford in 2014, with a thesis on mathematical modelling of infectious disease. He then held postdoctoral research positions in mathematical oncology at the Institut des Sciences de l'Evolution de Montpellier (2014-2017), ETH Zurich (2017-2020), and the University of Zurich (2018-2020). He joined City as a Lecturer in July 2020 and was promoted to Senior Lecturer in August 2024.
Qualifications
- Advance HE fellowship, Advance HE, United Kingdom, June 2024
- DPhil, University of Oxford, United Kingdom, October 2009 - January 2014
- MMath, University of York, United Kingdom, October 1999 - July 2003
Employment
- Senior Lecturer in Applied Mathematics, City, University of London, United Kingdom, August 2024 - present
- Lecturer in Applied Mathematics, City, University London, United Kingdom, July 2020 - July 2024
- Postdoctoral researcher, University of Zurich, Switzerland, May 2018 - June 2020
- Postdoctoral researcher, Swiss Federal Institute of Technology in Zurich, Switzerland, February 2017 - June 2020
- Postdoctoral researcher, Institut des Sciences de l’Evolution de Montpellier, France, January 2014 - January 2017
Research students
Kate Bostock
Attendance: October 2024 - September 2028, full-time
Thesis title: Informing the design of cancer clinical trials through mathematical modelling, preclinical data analyis and machine learning
Role: 1st Supervisor
Alexandru Chitiga
Attendance: July 2024 - June 2028, full-time
Thesis title: Describing and predicting evolution using universal tree shape indices
Role: 1st Supervisor
Kimberley Verity
Attendance: October 2022 - September 2026, full-time
Thesis title: Mathematical theory of tumour evolutionary modes
Role: 1st Supervisor
Blair Colyer
Attendance: July 2021 - June 2025, full-time
Thesis title: Combined Bayesian And Theoretical Analysis of Cancer Treatment Strategies and Incidence Data
Role: 1st Supervisor
Further information: Coauthor of "Warlock: an automated computational workflow for simulating spatially structured tumour evolution" arXiv 2301.07808 (2023)
Veselin Manojlovic
Attendance: September 2020 - May 2024, full-time
Thesis title: Mathematical Classification of the Modes of Tumour Evolution
Role: 1st Supervisor
Further information: Coauthor of "Robust, Universal Tree Balance Indices" Systematic Biology 71;1210–1224 (2022) Coauthor of "Warlock: an automated computational workflow for simulating spatially structured tumour evolution" arXiv 2301.07808 (2023) Awarded nine-month Enrichment Scheme placement at the Alan Turing Institute
Publications
Publications by category
Conference papers and proceedings (2)
- Isabelle, P.L.O., Tisserand, A., Noble, R., Dagher, T., Maslah, N., Mosca, M.... Vainchenker, W. INVESTIGATING THE MECHANISMS OF IFNALPHA THERAPY IN JAK2V617F AND CALR MUTATED MYELOPROLIFERATIVE NEOPLASMS. .
- Tisserand, A., Noble, R., Mosca, M., Marzac, C., Vertenoeil, G., Campario, H.... Plo, I. Predicting the Long-Term Efficacy of Ifnα in JAK2V617F and Calr-Mutated MPN Patients. .doi:10.1182/blood-2019-127903
Journal articles (21)
- Thomas, F., M. Dujon, A., Marusyk, A., DeGregori, J., Fontanella, A., Bieuville, M.... Gatenby, R. (2026). When effective anticancer therapies are, in fact, destabilizing the tumor’s Group Phenotypic Composition. npj Precision Oncology. doi:10.1038/s41698-026-01536-5
- Stein, A., Bostock, K., Kizhuttil, R., Bak, M. and Noble, R. (2026). Selective sweep probabilities in spatially expanding populations. Nature Communications, 17(1). doi:10.1038/s41467-026-69363-7
- Patil, S., Ahmed, A., Viossat, Y. and Noble, R. (2026). Preventing evolutionary rescue in cancer using two-strike therapy. GENETICS, 232(2). doi:10.1093/genetics/iyaf255
- Colyer, B., Bak, M., Basanta, D. and Noble, R. (2024). A seven‐step guide to spatial, agent‐based modelling of tumour evolution. Evolutionary Applications, 17(5). doi:10.1111/eva.13687
- West, J., Adler, F., Gallaher, J., Strobl, M., Brady-Nicholls, R., Brown, J.... Anderson, A.R.A. (2023). A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation. eLife, 12. doi:10.7554/elife.84263
- Lemant, J., Le Sueur, C., Manojlović, V. and Noble, R. (2022). Robust, Universal Tree Balance Indices. Systematic Biology, 71(5), pp. 1210-1224. doi:10.1093/sysbio/syac027
- Noble, R., Burri, D., Le Sueur, C., Lemant, J., Viossat, Y., Kather, J.N.... Beerenwinkel, N. (2021). Spatial structure governs the mode of tumour evolution. Nature Ecology & Evolution, 6(2), pp. 207-217. doi:10.1038/s41559-021-01615-9
- Mosca, M., Hermange, G., Tisserand, A., Noble, R., Marzac, C., Marty, C.... Plo, I. (2021). Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms. Blood, 138(22), pp. 2231-2243. doi:10.1182/blood.2021010986
- Kuosmanen, T., Cairns, J., Noble, R., Beerenwinkel, N., Mononen, T. and Mustonen, V. (2021). Drug-induced resistance evolution necessitates less aggressive treatment. PLOS Computational Biology, 17(9), pp. e1009418-e1009418. doi:10.1371/journal.pcbi.1009418
- Noble, R.J., Walther, V., Roumestand, C., Hochberg, M.E., Hibner, U. and Lassus, P. (2021). Paracrine Behaviors Arbitrate Parasite-Like Interactions Between Tumor Subclones. Frontiers in Ecology and Evolution, 9. doi:10.3389/fevo.2021.675638
- Viossat, Y. and Noble, R. (2021). A theoretical analysis of tumour containment. Nature Ecology & Evolution, 5(6), pp. 826-835. doi:10.1038/s41559-021-01428-w
- Dujon, A.M., Aktipis, A., Alix‐Panabières, C., Amend, S.R., Boddy, A.M., Brown, J.S.... Ujvari, B. (2021). Identifying key questions in the ecology and evolution of cancer. Evolutionary Applications, 14(4), pp. 877-892. doi:10.1111/eva.13190
- Noble, R., Burley, J.T., Le Sueur, C. and Hochberg, M.E. (2020). When, why and how tumour clonal diversity predicts survival. Evolutionary Applications, 13(7), pp. 1558-1568. doi:10.1111/eva.13057
- Bacevic, K., Noble, R., Soffar, A., Wael Ammar, O., Boszonyik, B., Prieto, S.... Fisher, D. (2017). Spatial competition constrains resistance to targeted cancer therapy. Nature Communications, 8(1). doi:10.1038/s41467-017-01516-1
- Hochberg, M.E. and Noble, R.J. (2017). A framework for how environment contributes to cancer risk. Ecology Letters, 20(2), pp. 117-134. doi:10.1111/ele.12726
- Vasse, M., Noble, R.J., Akhmetzhanov, A.R., Torres-Barceló, C., Gurney, J., Benateau, S.... Hochberg, M.E. (2017). Antibiotic stress selects against cooperation in the pathogenic bacterium Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences, 114(3), pp. 546-551. doi:10.1073/pnas.1612522114
- Noble, R., Kaltz, O., Nunney, L. and Hochberg, M.E. (2016). Overestimating the role of environment in cancers. Cancer Prevention Research, 9(10), pp. 773-776. doi:10.1158/1940-6207.CAPR-16-0126
- Noble, R., Kaltz, O. and Hochberg, M.E. (2015). Peto's paradox and human cancers. Philosophical Transactions of the Royal Society B: Biological Sciences, 370(1673), pp. 20150104-20150104. doi:10.1098/rstb.2015.0104
- Noble, R., Christodoulou, Z., Kyes, S., Pinches, R., Newbold, C.I. and Recker, M. (2013). The antigenic switching network of Plasmodium falciparum and its implications for the immuno-epidemiology of malaria. eLife, 2. doi:10.7554/elife.01074
- Noble, R. and Recker, M. (2012). A Statistically Rigorous Method for Determining Antigenic Switching Networks. PLoS ONE, 7(6), pp. e39335-e39335. doi:10.1371/journal.pone.0039335
- Fastman, Y., Noble, R., Recker, M. and Dzikowski, R. (2012). Erasing the Epigenetic Memory and Beginning to Switch—The Onset of Antigenic Switching of var Genes in Plasmodium falciparum. PLoS ONE, 7(3), pp. e34168-e34168. doi:10.1371/journal.pone.0034168
Working papers (2)
- Manojlovic, V., Gabbutt, C., Shibata, D. and Noble, R.J. (2026). Fluctuating DNA methylation sites encode colorectal tumour growth history.
- Noble, R., Kaltz, O. and Hochberg, M.E. Statistical interpretations and new findings on Variation in Cancer Risk Among Tissues.